Rentokil Initial (RKLIF) Shares Outstanding (Weighted Average) (2020 - 2025)

Rentokil Initial (RKLIF) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $41.0 million in Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $41.0 million, down 98.73% year-over-year; the trailing twelve-month figure through Dec 2025 was $41.0 million (down 98.73% YoY), and the FY2025 annual result was $41.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) retreated to $41.0 million in Q4 2025 per RKLIF's latest filing, from $20000.0 billion in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $121500.0 billion in Q2 2022 and troughed at $41.0 million in Q4 2025.
• A 5-year average of $15727.1 billion and a median of $3.2 billion in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Weighted Average) slumped 99.99% in 2023, then soared 113079.21% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $2.5 billion in 2021, then slipped by 6.24% to $2.3 billion in 2022, then surged by 32.98% to $3.1 billion in 2023, then grew by 3.62% to $3.2 billion in 2024, then sank by 98.73% to $41.0 million in 2025.
• Business Quant data shows RKLIF's Shares Outstanding (Weighted Average) at $41.0 million in Q4 2025, $20000.0 billion in Q2 2025, and $3.2 billion in Q4 2024.